Back to results
RecruitingPhase 2

Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.

NCT06450314

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centre Eugène marquis

Rennes, France

Contact

Clara Guyonneau, PharmD

+33 (0) 1 44.23.04.65c-guyonneau@unicancer.fr
View on ClinicalTrials.gov
Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests. — TrialFind